Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

735 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of the association between prospectively collected immune-related adverse events and survival in patients with solid tumor treated with immune-checkpoint blockers, taking into account immortal-time bias.
Kfoury M, Najean M, Lappara A, Voisin AL, Champiat S, Michot JM, Laghouati S, Robert C, Besse B, Soria JC, Lambotte O, Massard C, Marabelle A, Texier M. Kfoury M, et al. Among authors: soria jc. Cancer Treat Rev. 2022 Nov;110:102452. doi: 10.1016/j.ctrv.2022.102452. Epub 2022 Aug 10. Cancer Treat Rev. 2022. PMID: 35998515 Free article. Review.
[Predicting response to Iressa: unexpected mechanism].
Besse B, Le Chevalier T, Soria JC. Besse B, et al. Among authors: soria jc. Med Sci (Paris). 2004 Aug-Sep;20(8-9):750-1. doi: 10.1051/medsci/2004208-9750. Med Sci (Paris). 2004. PMID: 15361339 Free article. French. No abstract available.
[EGFR-targeted therapies: what's new?].
Vignot S, Besse B, Soria JC, Milano G, Spano JP. Vignot S, et al. Among authors: soria jc. Bull Cancer. 2006 Jan;93(1):13-8. Bull Cancer. 2006. PMID: 16455501 Free article. Review. French.
Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma.
Escudier B, Lassau N, Angevin E, Soria JC, Chami L, Lamuraglia M, Zafarana E, Landreau V, Schwartz B, Brendel E, Armand JP, Robert C. Escudier B, et al. Among authors: soria jc. Clin Cancer Res. 2007 Mar 15;13(6):1801-9. doi: 10.1158/1078-0432.CCR-06-1432. Clin Cancer Res. 2007. PMID: 17363536 Clinical Trial.
Targeted therapies in lung cancer.
Besse B, Ropert S, Soria JC. Besse B, et al. Among authors: soria jc. Ann Oncol. 2007 Jul;18 Suppl 9:ix135-42. doi: 10.1093/annonc/mdm308. Ann Oncol. 2007. PMID: 17631566 Free article. Review. No abstract available.
735 results